Values First Advisors
MIRM icon

Values First Advisors’s Mirum Pharmaceuticals MIRM Stock Holding History

Values First Advisors’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$792K Sell
9,262
-217
-2% -$22.6K 0.37% 75
2026
Q2 		$1.11M Buy
9,479
+82
+0.9% +$8.23K 0.51% 62
2026
Q1 		$868K Sell
9,397
-7,027
-43% -$661K 0.45% 62
2025
Q4 		$1.3M Sell
16,424
-2,288
-12% -$164K 0.67% 46
2025
Q3 		$1.37M Sell
18,712
-920
-5% -$58.5K 0.73% 46
2025
Q2 		$999K Buy
19,632
+1,514
+8% +$67.4K 0.54% 55
2025
Q1 		$818K Sell
18,118
-1,722
-9% -$81.2K 0.48% 56
2024
Q4 		$820K Sell
19,840
-3,885
-16% -$162K 0.45% 62
2024
Q3 		$925K Buy
23,725
+3,971
+20% +$158K 0.5% 54
2024
Q2 		$675K Sell
19,754
-1,654
-8% -$43.4K 0.4% 67
2024
Q1 		$538K Buy
21,408
+4,668
+28% +$128K 0.32% 93
2023
Q4 		$494K Sell
16,740
-21,179
-56% -$641K 0.3% 108
2023
Q3 		$1.2M Buy
+37,919
New +$1.04M 0.77% 41
2023
Q2 		– Sell
-8,497
Closed -$204K – 269
2023
Q1 		$204K Buy
+8,497
New +$194K 0.13% 134

Other funds holding MIRM

Essex Investment Management
Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return
Secure Asset Management
Secure Asset Management Troy, Michigan $753M AUM 20.9% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
AMI Asset Management
AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Yorktown Management & Research Company
Yorktown Management & Research Company Forest, Virginia $150M AUM 39.02% 1-Year Est. Return
Juncture Wealth Strategies
Juncture Wealth Strategies Scottsdale, Arizona $390M AUM 19.15% 1-Year Est. Return
NorthCrest Asset Manangement
NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return

Values First Advisors's MIRM Position: Q3 2026 in Review

Values First Advisors reduced its Mirum Pharmaceuticals (MIRM) stake by 2.3% in Q3 2026, selling an estimated $22.6K and leaving 9,262 shares worth $792K. The position accounts for 0.37% of the portfolio, ranked #75.

Values First Advisors first reported a position in MIRM in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.37M in Q3 2025. 49 funds tracked by Wall St. Rank hold MIRM as of Q3 2026.

  • Values First Advisors held 9,262 shares of Mirum Pharmaceuticals worth $792K as of Q3 2026.
  • Values First Advisors sold 217 Mirum Pharmaceuticals shares in Q3 2026, an estimated $22.6K.
  • Mirum Pharmaceuticals made up 0.37% of Values First Advisors's portfolio in Q3 2026, its #75 holding.
  • Values First Advisors first reported a position in Mirum Pharmaceuticals in Q1 2023 and has held it in 14 quarters since.
  • Values First Advisors's Mirum Pharmaceuticals position peaked at $1.37M in Q3 2025.
  • 49 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2026.

Based on Values First Advisors's 13F filing for Q3 2026, filed 23 Oct 2026.